Pfizer Inc.
PFE
NYSE
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
12/31/2023 | 10/01/2023 | 07/02/2023 | 04/02/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Net Income | -3.37B | -- | 2.33B | 5.54B | 4.99B |
Total Depreciation and Amortization | 1.67B | -- | 1.57B | 1.47B | 1.51B |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -1.51B | -- | -1.19B | -293.00M | -359.00M |
Change in Net Operating Assets | 8.45B | -- | -3.92B | -5.51B | 2.44B |
Cash from Operations | 5.24B | -- | -1.21B | 1.21B | 8.58B |
Capital Expenditure | -1.04B | -- | -914.00M | -1.14B | -1.00B |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -43.41B | -- | -25.00M | -- | -16.77B |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 33.45B | -- | -24.55B | 4.45B | 13.36B |
Cash from Investing | -11.00B | -- | -25.49B | 3.32B | -4.41B |
Total Debt Issued | 7.67B | -- | 30.63B | 237.00M | -866.00M |
Total Debt Repaid | 103.00M | -- | -1.00B | -269.00M | -1.91B |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | 0.00 |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -2.32B | -- | -2.32B | -2.30B | -2.25B |
Other Financing Activities | -18.00M | -- | -141.00M | -436.00M | 7.00M |
Cash from Financing | 5.44B | -- | 27.17B | -2.77B | -5.02B |
Foreign Exchange rate Adjustments | -1.00M | -- | -5.00M | -2.00M | -26.00M |
Miscellaneous Cash Flow Adjustments | -2.00M | -- | -1.00M | -- | -1.00M |
Net Change in Cash | -317.00M | -- | 475.00M | 1.75B | -870.00M |